Some researchers support the first view because low or absent levels of Cav-1 mRNA and protein can be seen in tumor tissue samples from human primary breast cancer patients, oncogene-transformed cells, transgenic mouse breast cancer models, and some human or mouse transformed epithelial cell lines (Razani et al., 2000). This evidence concerns the gene CAV1 and breast carcinoma.